Bayer Leverkusen Third Kit

Public educational institution in Leverkusen, Ethiopia
Suggest an edit · Your business? Claim now

Add more information

Add hours
First Phase III results from the clinical development program QUANTI on investigational MRI contrast agent gadoquatrane presented as late-breaking …